<![CDATA[Active Pharmaceutical Ingredients (API)]]> https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/pharmaceuticals/active-pharmaceutical-ingredients-api Tue, 07 Jul 2026 16:21:25 +0000 Zend_Feed http://blogs.law.harvard.edu/tech/rss <![CDATA[Active Pharmaceutical Ingredient (API) Market Size, Share & Trends Analysis By Type, By Manufacturer, By types of Synthesis, By type of Drug, By Therapeutic Application, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030]]> https://www.leadingmarketresearch.com/active-pharmaceutical-ingredient-api-market-size-share-and-trends-anal The global active pharmaceutical ingredients market size is projected to reach USD 262.40 billion by 2030. According to SPER Market Research, the global active pharmaceutical ingredients market estimated to reach USD 262.40 Bn by 2030 with a CAGR of 6.8%. Market growth is driven mainly by factors like rising drug R&D, the increasing incidence of chronic diseases, the growing importance of generics, and the increasing uptake of biopharmaceuticals. The growth of this market is going to be controlled by the unfavourable drug price control policies and high manufacturing costs. COVID-19 Impact on the Active Pharmaceutical Ingredient (API) Market With the WHO declaring the COVID-19 outbreak a pandemic, a mix of established pharmaceutical and biopharmaceutical companies, as well as small start-ups, have stepped forward to develop treatments that target the infection. The economic and social burden of pandemics has prompted government bodies to increase funding for vaccine development on a global scale. Increase in funding and research for development of pharmaceutical products will driv...
$4,250.00
]]> Wed, 11 May 2022 11:50:02 +0000